People with liver cancer that cannot be treated with surgical resection or transplantation could have an increased two-year survival if they are given chemoembolisation-a procedure in which blood supply to the tumour combined with the effect of chemotherapy inhibits cancer growth.
There is no standard treatment for liver cancer when surgery, transplantation, or percutaneous treatment is not possible, which applies to around three-quarters of all liver cancer cases. Arterial embolisation-the restriction of blood supply to the tumour-is widely used, but there is uncertainty whether it has a survival benefit.
Jordi Bruix and Josep Llovet from Hospital Clinic, Barcelona, Spain, lead a multicenter randomised trial among 112 cirrhotic patients with unresectable liver cancer to assess the survival benefits of arterial embolisation (use of gelatin sponge to block blood flow to the tumour) or chemoembolisation (gelatin sponge plus the chemotherapeutic drug doxorubicin) compared with conservative treatment.
The trial was stopped when it became apparent that chemoembolisation had a substantial survival benefit compared with conservative treatment. 25 of 37 patients assigned embolisation, 21 of 40 assigned chemoembolisation, and 25 of 35 assigned conservative treatment died. Survival probabilities at 1 year and 2 years were 75% and 50% for embolisation; 82% and 63% for chemoembolisation, and 63% and 27% for conservative treatment.
Jordi Bruix comments: “While we wait for confirmatory studies and from now on, chemoembolisation should become the standard approach for a selected group of candidates (unresectable intermediate hepatocellular carcinoma and preserved liver function).”
Richard Lane | Source: alphagalileo
More articles from Health and Medicine:
Nearly half of Americans believe H1N1 outbreak is over
08.02.2010 | Harvard School of Public Health
More smokers than non-smokers accept HPV vaccination for their daughters
08.02.2010 | American Association for Cancer Research
08.02.2010 | Studies and Analyses
Princeton scientist makes a leap in quantum computing
08.02.2010 | Information Technology
Sweet! -- sugar plays key role in cell division
08.02.2010 | Life Sciences
Asia-Pacific Symposium on Information and Telecommunication Technologies 2010 (APSITT 2010)
04.02.2010 | Event News
The Engineering Conference (EnCon 2010)
04.02.2010 | Event News
Homeland Security Science and Technology University Network Summit
01.02.2010 | Event News